According to a newly published article in BJU International, a new prostate cancer registry (Prostate Cancer Outcomes Registry — Australia and New Zealand or PCOR-ANZ) has been established to monitor outcomes of prostate cancer treatment and care “in a cost-effective manner”. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: Australia, New Zealand, outcomes, registry, research | 5 Comments »
In New Zealand, over the past few years, there has been a considerable increase in the use of PSA testing in an (unorganized) attempt to increase the probability of the early identification of men at risk for clinically significant prostate cancer. And, as we all know, the application of the PSA test to “screen” populations for prostate cancer is controversial (to say the least). … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Diagnosis, New Zealand, PSA, risk, test | 2 Comments »
A report in New Zealand’s Old Dominion Post would appear to typify a classic type of sad over-reaction to the results of the recent Norrkoping screening study (on which we commented last week). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: New Zealand, PSA, screening, testing | 4 Comments »
Our third report today covers such topics as:
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: biopsy, blood, circulating tumor cells, CTCs, Diagnosis, DNA, functional, IMRT, MRI, New Zealand, nomogram, radical prostatectomy, risk, technique, treatment planning | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 